Muir, A. J., McHutchison, J. G., Patel, K., Clary, G., & Gagliardi, J. P. (2006). Sertaline for the Prevention of Depression with HCV Therapy. In American Journal of Gastroenterology (Vol. 101, pp. S163–S164). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.14309/00000434-200609001-00360

Muir, Andrew J., John G. McHutchison, Keyur Patel, Greg Clary, and Jane P. Gagliardi. “Sertaline for the Prevention of Depression with HCV Therapy.” In American Journal of Gastroenterology, 101:S163–64. Ovid Technologies (Wolters Kluwer Health), 2006. https://doi.org/10.14309/00000434-200609001-00360.

Muir AJ, McHutchison JG, Patel K, Clary G, Gagliardi JP. Sertaline for the Prevention of Depression with HCV Therapy. In: American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health); 2006. p. S163–4.

Muir, Andrew J., et al. “Sertaline for the Prevention of Depression with HCV Therapy.” American Journal of Gastroenterology, vol. 101, Ovid Technologies (Wolters Kluwer Health), 2006, pp. S163–64. Crossref, doi:10.14309/00000434-200609001-00360.

Muir AJ, McHutchison JG, Patel K, Clary G, Gagliardi JP. Sertaline for the Prevention of Depression with HCV Therapy. American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health); 2006. p. S163–S164.